With the development of biopharmaceuticals, comprehensive characterization of the key quality attributes of antibodies has become the focus and difficulty in antibody drug development. As a biophysical expert, CD BioSciences is committed to providing a variety of advanced biophysical analysis techniques for the comprehensive characterization of antibody structure. Our services cover from preliminary characterization to detailed high-resolution structural analysis, further helping customers make important progress in antibody research and development.
In recent years, monoclonal antibodies (mAbs) have rapidly become a successful class of biologics for tumor targeting and immunotherapy. The efficacy of mAbs is closely related to their structure. Accurate antibody structural information can not only reveal its mechanism of action but also guide the design, optimization, and clinical application of antibody drugs. Ensuring the structure of complementary determining regions (CDRs) so that they can bind to antigens is the key to the efficacy of mAbs. With the rapid development of biophysical technology, high-resolution structural analysis methods continue to emerge, allowing us to explore the three-dimensional structure and dynamic behavior of antibodies.
Figure 1. Therapeutic monoclonal antibodies crystallize. (Brader M L, et al., 2017)
X-ray crystallography is the gold standard method for analyzing high-resolution three-dimensional structures of antibodies. Through this technology, we can provide atomic-level structural information to help customers understand the mechanism of action of antibodies and their interaction with antigens. Our services include high-resolution structural elucidation, complex sample processing, automated crystal screening, and data processing and modeling to ensure the accuracy and reliability of the results.
NMR spectroscopy is a powerful tool for studying the native conformation of antibodies in solution and their dynamic behavior. We provide services for kinetic and conformational studies, and a wide range of samples, and can handle antibodies and complexes up to 150 kDa. In addition, through multidimensional NMR technology and isotope labeling, we can obtain higher resolution and more detailed structural information.
SPR technology is used to monitor the interaction between antibodies and antigens in real time, providing binding kinetics and affinity data. Our service features include real-time interaction analysis without labeling, high-sensitivity detection, multi-channel analysis, and detailed kinetic parameters (such as association rate and dissociation rate), providing important reference data for drug discovery and development.
DSC technology is used to measure the thermal stability of antibodies, helping to evaluate the thermodynamic properties and denaturation temperature (Tm) of antibodies. Our services include stability analysis, widely applicable sample processing, high-throughput screening, and quantitative analysis, providing customers with detailed thermodynamic data on antibody stability.
Our platform uses Size Exclusion Chromatography coupled with Multi-Angle Light Scattering (SEC-MALS), hydrophobic interaction chromatography (HIC), ion exchange chromatography (IEX), and other technologies for antibody structural characterization.
CD BioSciences is committed to providing the highest quality service and support for your research. If you are interested in our services, please feel free to contact us.
Reference
CD BioSciences is a biotechnology company focused on biophysical services. We are proficient in both chemistry and biophysics, and have a comprehensive biophysical platform containing a wide range of advanced technologies.